Gene editing Archives

News and Trends 6 Aug 2021

Artios’ €129M Series C Pushes Limits of DNA Repair in Cancer

The UK firm Artios Pharma raised a huge Series C round last week in one of many efforts to develop cancer drugs that target the DNA repair systems of our cells. Artios Pharma bagged €129M (£110M) last week in a venture capital round led by the US-based firms Omega Funds and TCG X. The proceeds […]

August 6, 2021 - 4 minutesmins - By Anita Chakraverty

Best in Biotech 30 Jun 2021

Scotland’s Top 10 Biotech Companies to Watch Out For

Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial biotech. Let’s pick up the bagpipes as we tour the top 10 biotech companies in Scotland. Scotland is the UK’s second-most populous country, boasting picturesque scenery, a rich history, and a strong focus on sustainability. There is a diverse range […]

June 30, 2021 - 11 minutesmins - By Jonathan Smith

Interview 5 Apr 2021

Base Editing: The Next Frontier in Genome Editing Technology

Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base editing technology. In less than a decade, the advent of CRISPR-Cas9 has made gene editing easier and faster than ever. But CRISPR, as well as earlier genome editing tools, have a series of technical limitations, […]

April 5, 2021 - 4 minutesmins - By Larissa Warneck-Silvestrin

Interview 3 Mar 2021

The Promises of CRISPR Genome Editing in Biomedicine

Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing over other technologies and what the future holds for the genome editing field. For decades, gene editing required engineering DNA-cutting enzymes, such as zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), for every specific […]

March 3, 2021 - 5 minutesmins - By Larissa Warneck-Silvestrin

In Depth 1 Mar 2021

How Are European Biotechs Tackling the Cardiovascular Disease Problem?

Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality globally, making up over 30% of all deaths worldwide. While there are many established treatments on the market, there’s still a need for more effective treatments – can biotech companies provide the answer? We all know that frequent exercise, a […]

March 1, 2021 - 9 minutesmins - By Farhan Mitha

In Depth 3 Feb 2021

Detecting Gene-Edited Food: The EU’s Nightmare

The EU imposed stringent controls on the commercialization of gene-edited food back in 2018. Years later, regulators are still working in the dark, with no established tests in place. The EU has some of the strictest food regulations in the world surrounding the cultivation and commercialization of genetically modified organisms (GMOs), which it defines as organisms whose […]

February 3, 2021 - 10 minutesmins - By Jonathan Smith

Interview 1 Feb 2021

Democratized DNA Synthesis: A Game-Changer Against Covid-19

DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO of DNA Script, discusses the French company’s plans to protect research from future disruptions by giving every lab the ability to synthesize its own DNA molecules. The Covid-19 pandemic has highlighted more than ever the […]

February 1, 2021 - 6 minutesmins - By Jonathan Smith

Best in Biotech 11 Jan 2021

The 21 European Biotech Companies To Watch in 2021

As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies likely to make a big splash in the biotechnology sector over the next year. There were many memorable moments for the European biotech industry in 2020. The Covid-19 pandemic took over the media and many […]

January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin

News and Trends 29 Jul 2020

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Update on 29/07/2020: DNA Script has increased the total raised in its Series B round to €80M ($89M). The additional funds will support the commercial launch of the company’s benchtop DNA printer, which is designed to allow same-day DNA synthesis directly in the lab bench. The company is planning to launch a beta testing program […]

July 29, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Mar 2020

Evonetix Raises €27M Series B to Progress DNA Synthesis Technology

UK synthetic biology company Evonetix raised €27M in Series B funding to develop its fast DNA synthesis technology and produce a working prototype of the company’s desktop platform. New investor Foresite Capital, a US-based VC firm, led the round, although all the company’s earlier Series A investors, such as the tech-focused VC’s Draper Esprit and […]

March 2, 2020 - 2 minutesmins - By Helen Albert

News and Trends 24 Jan 2020

Broad Institute Loses Appeal on European CRISPR Patent

A decision from the Boards of Appeal at the European Patent Office has revoked the claim of the Broad Institute to general patents on CRISPR/Cas9 gene editing technology, strengthening the position of its opponent UC Berkeley in Europe. The Broad Institute in Cambridge, US, is one of the main contenders in the ongoing battle for […]

January 24, 2020 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2020

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

A DNA data storage project, involving French biotech DNA Script, has been awarded a contract worth up to €20.7M from the US Intelligence Advanced Research Projects Activity agency to develop a prototype instrument able to store and retrieve 1 terabyte of information in 24 hours. The Molecular Encoding Consortium, led by Robert Nicol at the Broad […]

January 18, 2020 - 3 minutesmins - By External Contributor

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us